Clinical Trials Browser

Phase 3 × Ovarian Neoplasms × Diet Therapy × Clear all

NCT06954584 2025-06-24

Fluzoparib+Bevacizumab/Dietary Intervention vs Fluzoparib Monotherapy as First-line Maintenance in HRD+/- Advanced Ovarian Cancer

Phase 3 Recruiting

Ovarian Neoplasms